The present disclosure relates to the compounds of Formula I, or its stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof and their evaluation for medicinal use. The present disclosure further provides a process for the preparation of the compounds of Formula I.The present disclosure also relates to the synthesis and characterization of aforementioned compounds.